• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PLC181200
Medical Device Problem Code Device Endoleak (4074)
Health Effect - Clinical Code Clinical Endoleak (4843)
Date of Event 01/25/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
B3: the exact date of event is unknown, therefore the date of the reintervention was selected as date of event.D10: gore® excluder® aaa endoprosthesis - trunk ipsilateral leg endoprosthesis (rlt261212), gore® excluder® aaa endoprosthesis - contralateral leg endoprosthesis (plc121000), gore® excluder® aaa endoprosthesis - iliac extender endoprosthesis (pll161207).H3: other code and h6: code b20 - the device remains implanted, therefore no product evaluation could be performed.H6: b14 - as part of our routine quality procedures, each batch of devices undergoes comprehensive quality control testing and inspections prior to release for distribution.Gore reviewed the manufacturing records associated with the reported lot number and verified that all release criteria had been met.Based on the incident description and the subsequent investigation, no further information was provided to gore, we are unable to determine the cause of this incident and assign a root cause.Per the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to endoleak.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
It was reported to gore that a gore® excluder® aaa endoprosthesis (a total of (b)(4) components: one trunk-ipsilateral leg (rlt261212), two contralateral legs (plc121000 on the right, plc181200 on the left), and one iliac extender on the right) was implanted on (b)(6) 2018 for an emergency endovascular aneurysm repair (evar).In (b)(6) 2024, a follow-up with ct showed suboptimal seal in the left limb (plc181200).On (b)(6) 2024, a gore® excluder® iliac branch endoprosthesis (ceb231410 - sn (b)(6)) was implanted on the left side, landing in the plc181200.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
ida simson
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key18946243
Report Number3013164176-2024-02021
Device Sequence Number7966004
Product Code MIH
UDI-Device Identifier00733132618736
UDI-Public00733132618736
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/01/2020
Device Catalogue NumberPLC181200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/20/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured12/02/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10.
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-